|
MechanismIL-1RA inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Xinzhong Pharmaceutical Technology (Beijing) Co., Ltd.
0 Patents (Medical) associated with Xinzhong Pharmaceutical Technology (Beijing) Co., Ltd.
100 Deals associated with Xinzhong Pharmaceutical Technology (Beijing) Co., Ltd.
100 Translational Medicine associated with Xinzhong Pharmaceutical Technology (Beijing) Co., Ltd.